Skip to main content
. 2014 Oct 14;124(25):3817–3827. doi: 10.1182/blood-2014-07-587477

Figure 3.

Figure 3

Survival outcomes for AML patients. Kaplan-Meier estimates of DFS and OS are shown for AML patients (n = 138) by (A-B) their pretransplantation remission status, (C-D) cytogenetics by the refined MRC criteria in those tested (n = 131), and (E-F) Flt3/ITD status in those tested (n = 92).